Article Details

ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B - TradingView

Retrieved on: 2025-07-01 15:40:18

Tags for this article:

Click the tags to see associated articles and topics

ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B - TradingView. View article details on hiswai:

Excerpt

AbbVie ABBV announced that it has entered into a definitive agreement to acquire privately held biotech, Capstan Therapeutics, for up to $2.1 ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo